LOS ANGELES, Oct. 28, 2010 (GLOBE NEWSWIRE) -- CompuMed, Inc. (OTCBB:CMPD) (http://www.compumed.net), a telemedicine and medical informatics company, has entered into an agreement with Operation Samahan (http://www.operationsamahan.org) to provide CompuMed's CardioGramKids® electrocardiogram (ECG) telemedicine and CompuBridge™ electronic health record (EHR) services system wide to Operation Samahan's five community clinics and school health centers.
Operation Samahan operates one of the nation's leading community clinic organizations, providing San Diego County residents with nearly 50,000 patient visits per year at five community clinics and school health centers.
CompuMed's CardioGramKids Pediatric Screening Program provides ECG screening services to children and teenagers prior to taking psychotropic medications or participating in school or afterschool sports programs. CompuMed's CompuBridge service enables real-time integration of ECG and other data into a wide variety of EHR systems.
"We are very excited to partner with Operation Samahan to enhance the delivery of preventive medicine in San Diego County," said CEO Maurizio Vecchione. "With the extension of our school health center program into community clinics and our integration of ECG and EHR technologies, CompuMed remains at the forefront of ECG telemedicine. We are also well positioned to assist healthcare providers everywhere in making meaningful use of electronic health records technology in a way that is at once powerful and practical," Mr. Vecchione added.
CompuMed will provide Operation Samahan with the company's CardioGramKids ECG equipment and with over-reads performed remotely by CompuMed's pediatric cardiologists. CompuMed will also work with Operation Samahan to enable real-time integration of ECG results into their system wide EHR programs. ECG data combined with other personal diagnostic or treatment data in EHR systems can help alert physicians to a variety of significant health issues, including the cardiac impact of prescribed medications and other treatment regimens.
"We are very grateful to CompuMed for enabling us to provide our community clinic patients and local school children with state of the art ECG and EHR services that are both convenient and affordable," said Joel San Juan, CEO and Executive Director of Operation Samahan.
"The ability to access pediatric cardiologist overreads and integrate ECG and EHR data in such a practical manner greatly increases the range and scope of what we are able to provide here at the clinical level," said Operation Samahan Medical Director Maria T. Villa, M.D. "Our system wide deployment of CompuMed technology has the potential to result in a significant long-term reduction of morbidity and mortality associated with previously unrecognized cardiac conditions in our county's youth, particularly among the population we serve who may formerly have had limited access to such sophisticated services," added Dr. Villa.
For more information, visit CompuMed at http://www.compumed.net and follow at Twitter: @compumed.
About CompuMed
CompuMed, Inc. (OTCBB:CMPD) develops and markets products and services that combine advanced imaging with medical informatics. Its focus is on analysis and remote monitoring for patients with cardiovascular and musculoskeletal diseases. The company has specialized expertise and intellectual property in telemonitoring imaging and analysis designed to improve healthcare provider workflow and patient care while reducing costs. CompuMed is headquartered in Los Angeles and distributes its products worldwide both directly and through OEM partners.
Forward Looking Statements
Statements contained in this press release that are not historical facts, such as statements about prospective earnings, savings, revenue, operations, revenue and earnings growth, results of contracts and other financial results, are forward-looking statements pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. All such forward-looking statements including statements concerning the Company's plans, objectives, expectations and intentions are based largely on management's expectations and are subject to and qualified by risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements. These statements are subject to uncertainties and risks including, without limitation, competitive factors, outsourcing trends in the pharmaceutical industry, product and service demand and acceptance, changes in technology, ability to raise capital, the availability of appropriate acquisition candidates and/or business partnerships, economic conditions, the impact of competition and pricing, capacity and supply constraints or difficulties, government regulation and other risks identified in the Company's filings with the Securities and Exchange Commission including its Annual Report on Form 10-KSB and Quarterly Reports on Form 10-QSB. All such forward-looking statements are expressly qualified by these cautionary statements. The Company expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements to reflect events, conditions or circumstances on which any such statement is based after the date hereof, except as required by law.